Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05773768 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EHRA-PATHS: Clinical and Health Economic Evaluation of New Care Pathways

Study acronym: EHRA-PATHS
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Jan 1, 2026 to Jul 1, 2026 Trial completed · Final enrollment: 703 participants (planned 1300) · Eligibility criteria expanded, about 7 words · 2 more Show 5 more changesShow less
    • Trial completed
    • Final enrollment: 703 participants (planned 1300)
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 2 of 6 entries
    • Site details revised
  2. Primary and study completion dates: Jan 1, 2025 to Jan 1, 2026 Start date changed from estimate of Jun 1, 2024 to Mar 28, 2024v4 Show 1 more changeShow less
    • Start date changed from estimate of Jun 1, 2024 to Mar 28, 2024
  3. Trial status: Not Yet Recruiting to Recruiting Start date: Feb 1, 2024 to Jun 1, 2024v3 Show 1 more changeShow less
    • Start date: Feb 1, 2024 to Jun 1, 2024
  4. Start date: Sep 1, 2023 to Feb 1, 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In elderly atrial fibrillation (AF) patients, AF is usually a manifestation of risk factors and comorbidities not only limited to cardiovascular diseases. Especially in elderly often more than two comorbidities are present. The presence of comorbidities also affects outcomes in AF patients. Current healthcare systems are single-disease focused, which increases the risk of underdiagnosing, replicating diagnostic tests and adverse drug-drug interactions, placing a high burden on healthcare costs. Healthcare systems and hospitals are in need of new care pathways to address the complexity of multimorbid AF patients and to reduce costs. The EHRA-PATHS consortium set out to address this need for change in management for multimorbid, elderly AF patients in Europe through the development of new care pathways. The aim of this study is to evaluate the current management of risk factors and comorbidities, and subsequently implement the newly developed care pathways and evaluate if these pathways lead to better management of risk factors and comorbidities in multimorbid, elderly AF patients, compared to current standard care.
Trial Details
NCT Number NCT05773768
Lead Sponsor University Medical Center Groningen
Conditions Atrial Fibrillation
Enrollment 703 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov